Social Media Ideas for Alzheimer's Research

Alzheimer’s Research UK

www.alzheimersresearchuk.org Twitter: @ARUKnews Primary research areas Neurological Additional research areas Congenital disorders,  Ear,  Eye Grant types Early Career Fello...

Ask Mayo Clinic: New discoveries in Alzheimer’s research brings scientists closer to prevention and cures

Each discovery helps researchers better understand the disease and brings them closer to finding ways to prevent, slow or treat it.

New Alzheimer's drug repairs DNA damage and reduces brain inflammation

A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced infl...

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it

An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. The trea...

An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches

WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called...

Alzheimer's research: Columbia doctors pinpoint where the disease begins

Bill Ritter spoke with doctors at Columbia about Alzheimer's disease and their groundbreaking research.

Japan scientists identify clusters of protein believed to trigger Alzheimer’s disease

The discovery of a new seed of the amyloid beta protein could lead to early-stage therapy for neurodegenerative disease, according to researchers.

Marmoset Genome Unlocks Alzheimer’s Insights

A new study delivers the first gapless marmoset genome, mapping 76 Alzheimer's-linked genes and novel PSEN1 variants.

Trial Results for a PD-L1 Antibody Therapy to Reduce Inflammation in Alzheimer's Disease

Alzheimer's disease, and the other common age-related neurodegenerative conditions, are characterized by chronic inflammation in brain tissue. Aging in general is characterized by...

Researchers Work to Address Alzheimer’s and Dementia in Rural Communities

Experimental Alzheimer's drug shows promise targeting brain protein tau in study

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers r...

New experimental drug shows promise in slowing early Alzheimer’s

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

5 Recent Dementia Research Advances — From Blood Tests and Lithium to Lifestyle Changes

Learn more about these 5 recent dementia breakthroughs that highlight possible interventions, diagnosis methods, and treatments. 

ALZHEIMER'S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE

A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study.In a head-to-head comparison...

Mitochondrial Plaques in Alzheimer’s Brains Discovered

Researchers identified mitochondrial plaques, an intracellular form of pathology that forms early in Alzheimer's disease and offers a new target for treatment.

BLOOD TEST MAY HELP PREDICT RISK OF COGNITIVE DECLINE DUE TO ALZHEIMER'S A DECADE BEFORE SYMPTOMS APPEAR

Key Takeaways

An experimental Alzheimer's drug is showing some promise

An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments — by lowering levels of a brain protein called tau, researchers r...

Phase 1 Trial Validates Anti-PD-L1 Antibody for Alzheimer’s

IBC-Ab002, an anti-PD-L1 immunotherapy targeting systemic immune aging, is safe and reduces markers of neuronal damage in Alzheimer's patients.

A hidden Alzheimer’s tipping point may decide who gets dementia

Scientists have identified a possible tipping point that helps determine whether Alzheimer’s-related brain changes lead to dementia. The key may lie in how the brain’s immune cells...

Engineered Exosomes as a Treatment for Alzheimer's Disease

Exosomes are one category of extracellular vesicle secreted by cells, a membrane-wrapped package of molecules, one complex component of the extensive, incompletely mapped communica...

An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid

Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.

Scientists discover a protein that protects the brain from Alzheimer’s damage

A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atro...

Deep sleep brain waves offer protection against Alzheimer’s disease, new research shows

Poor sleep quality has been linked to cognitive decline, neurodegeneration and Alzheimer’s disease in older adults. A new international study led by Concordia researchers shows tha...